Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | CRHBP | P24387 | 1/20 | 0.45 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5391946 | 1.00 | MAPK1 (0.55) | MAPK1TSHRALOX12ALDH1A1KDM4E | |
| SCHEMBL1300746 | 1.00 | MAPK1 (0.55) | MAPK1TSHRALOX12ALDH1A1KDM4E | |
| Verbenone SCHEMBL4254806 | 0.83 | MAPK1 (0.50) | MAPK1TSHRALOX12ALDH1A1KDM4E | |
| SCHEMBL5297079 | 0.81 | MAPK1 (0.55) | MAPK1TSHRALOX12ALDH1A1KDM4E | |
| SCHEMBL11074361 | 0.81 | MAPK1 (0.55) | MAPK1TSHRALOX12ALDH1A1KDM4E | |
| SCHEMBL18339258 | 0.78 | MAPK1 (0.52) | MAPK1TSHRALOX12ALDH1A1KDM4E | |
| SCHEMBL18339257 | 0.78 | MAPK1 (0.52) | MAPK1TSHRALOX12ALDH1A1KDM4E | |
| SCHEMBL7743417 | 0.77 | ALOX12 (0.42) | MAPK1TSHRALOX12ALDH1A1KDM4E | |
| Piperitone SCHEMBL13728035 | 0.77 | ALOX12 (0.39) | MAPK1TSHRALOX12ALDH1A1KDM4E | |
| SCHEMBL14321805 | 0.74 | MAPK1 (0.47) | MAPK1TSHRALOX12ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1698 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250352444-A1 | Antimicrobial mixtures | SYMRISE AG (DE) | 2025-11-20 | — | — | US | claimed |
| US-20250325463-A1 | COMPOSITIONS (III) | SYMRISE AG (DE) | 2025-10-23 | — | — | US | claimed |
| US-12378173-B2 | Method of production of bicyclic hydrocarbons | CleanJoule, Inc. (US) | 2025-08-05 | — | — | US | claimed |
| US-20250197326-A1 | METHOD OF PRODUCTION OF BICYCLIC HYDROCARBONS | CleanJoule, Inc. (US) | 2025-06-19 | — | — | US | claimed |
| EP-4525822-A1 | ANTIMICROBIAL MIXTURES | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| CN-119255781-A | Antimicrobial mixtures | 西姆莱斯股份公司 | 2025-01-03 | — | — | CN | claimed |
| CN-119118895-A | Method for synthesizing 3-fluoropyrrole compound by palladium catalytic defluorination and cyclization | 南京工业大学 | 2024-12-13 | — | — | CN | claimed |
| EP-4472606-A1 | COMPOSITIONS (III) | Symrise AG (DE) | 2024-12-11 | — | — | EP | claimed |
| CN-119080711-A | Preparation method and application of myrtenyl-1, 3, 4-oxadiazole formylhydrazine compound | 南京林业大学 | 2024-12-06 | — | — | CN | claimed |
| US-5079000-A | Fungicides, bactericides, insecticides useful for stored fruits and vegetables, natural products | KURITA WATER INDUSTRIES LTD. (JP) | 1992-01-07 | — | — | US | claimed |
| EP-0247595-B1 | NEW AZAPHOSPHOLONES AND USE THEREOF | Studiengesellschaft Kohle mbH (DE) | 1992-01-02 | — | — | EP | claimed |
| US-4948597-A | WITH MYRTENAL OR THE CORRESPONDING METHYL KETONE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1990-08-14 | — | — | US | claimed |
| US-4900866-A | Azaphospholenes | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1990-02-13 | — | — | US | claimed |
| US-4774076-A | DENTIFRICES, MOUTHWASHES | LION CORPORATION (JP) | 1988-09-27 | — | — | US | claimed |
| EP-0150293-B1 | SUBSTRATE FOR OPTICAL RECORDING MEDIA | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-08-17 | — | — | EP | claimed |
| US-4743409-A | INJECTION MOLDING POLYVINYL ACETAL RESINS | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-05-10 | — | — | US | claimed |
| EP-0247595-A2 | New azaphospholones and use thereof | Studiengesellschaft Kohle mbH (DE) | 1987-12-02 | — | — | EP | claimed |
| US-4649044-A | DISCOLORATION INHIBITION | LION CORPORATION (JP) | 1987-03-10 | — | — | US | claimed |
| EP-0150293-A1 | Substrate for optical recording media | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1985-08-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352444-A1 | Antimicrobial mixtures | LRBA, MGLL, TAS2R50 | MAPK1 4274/4885TSHR 3863/4885ALOX12 185/4885 |
| US-20250197326-A1 | METHOD OF PRODUCTION OF BICYCLIC HYDROCARBONS | DHPS, CYP2E1, CYP11B2 | MAPK1 3325/4885TSHR 3387/4885ALOX12 76/4885 |
| US-20250325463-A1 | COMPOSITIONS (III) | NISCH, TAS1R3, TAS2R3 | MAPK1 4320/4885TSHR 2980/4885ALOX12 88/4885 |
| US-12378173-B2 | Method of production of bicyclic hydrocarbons | DHPS, CYP2E1, CYP11B2 | MAPK1 3325/4885TSHR 3387/4885ALOX12 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.